Obstructive Sleep Apnoea (OSA) in patients with type 2 diabetes and the effect of continuous positive airway pressure (CPAP) treatment on diabetic control, insulin resistance and blood pressure

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN28644636

Enrollment

Registered

2005-09-14

Start date

2004-06-15

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

OSA and coexisting Type 2 diabetes Nervous System Diseases Sleep apnoea

Interventions

CPAP and Sham (placebo) CPAP

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Age 18-75 2. Type 2 diabetes 3. OSA with more than 10 >4% SaO2 dips per hour on sleep study 4. Epworth Sleepiness Score >9

Exclusion criteria

Exclusion criteria: 1. Unstable diabetes 2. Respiratory failure requiring urgent nocturnal ventilation

Design outcomes

Primary

Measure	Time frame
HbA1c% change	—

Secondary

Measure	Time frame
Insulin resistance measured by euglycaemic clamp and homeostatic model assessment, blood pressure	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026